Toward Making Sperm in the Lab

Researchers devise a technique for creating gametes from murine embryonic stem cells.

Written byRina Shaikh-Lesko
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, L.A. DAWSONScientists in China have moved one step closer to stem cell–based treatments for infertility, reporting their creation of sperm-like cells from mouse embryonic stem cells. Stem cell researchers have for years worked to create sex cells from stem cells, but coaxing stem cells to undergo meiosis in vitro was a major stumbling block in efforts to create sperm or ova from progenitors. The team, led by Jiahao Sha of Nanjing University, is the first to produce sperm-cell precursors called round spermatids entirely in vitro. The group’s results appeared in Cell Stem Cell today (February 25).

“It’s a good piece of work that really sets the stage for so many different fields by putting together pieces necessary to de novo derive germ cells and use them for reproductive purposes,” said Brian Hermann, a reproductive biologist and stem cell researcher at the University of Texas, San Antonio, who was not involved in the work. “The fact they were able to complete meiosis in vitro from germ cells derived from pluripotent stem cells is really a major advance,” he added.

Sha and colleagues first induced murine embryonic stem cells to differentiate into cells that resembled primordial germ cells—precursors to haploid gametes. They then placed these cells in culture containing hormones like testosterone. This culture imitated the environment that primordial germ cells are exposed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies